CFR:SIXCompagnie Financiere Richemont SA Analysis
Data as of 2026-05-15 - not real-time
$134.61
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Cullen/Frost Bankers is trading at $134.61, comfortably below its 20‑day SMA of 140.29 and the 50‑day SMA of 138.19, indicating a short‑term price weakness that contrasts with the overall bullish trend direction flagged by the longer‑term averages. The RSI of 37 points to oversold conditions, while the MACD histogram remains negative, suggesting continued bearish momentum in the near term. Support sits at $133.36 and the next meaningful resistance is near $147.33, giving the stock a clear technical corridor. Fundamentally, the bank boasts a solid dividend yield of 3 % with a modest 39 % payout ratio, a respectable ROE of 15 % and a forward PE of 12.3, all of which support dividend sustainability. Recent earnings have been encouraging: Q1 EPS of $2.65 beat the consensus by nearly 7 % and revenue of $597.1 M topped expectations by 2 %, driven by strong loan growth. A discounted cash‑flow model places fair value at roughly $206, implying an upside of about 11 % from current levels. These combined technical and fundamental signals suggest that the stock is undervalued and positioned for a rebound, especially if earnings momentum continues.
Given the moderate volatility (≈20 % over 30 days), low beta, and stable trading volume, the risk profile is balanced, making the stock a suitable candidate for investors seeking both income and modest capital appreciation. The consensus analyst rating of “hold” reflects caution, but the quantitative upside and dividend appeal tilt the case toward a buy stance across medium and long horizons.
Given the moderate volatility (≈20 % over 30 days), low beta, and stable trading volume, the risk profile is balanced, making the stock a suitable candidate for investors seeking both income and modest capital appreciation. The consensus analyst rating of “hold” reflects caution, but the quantitative upside and dividend appeal tilt the case toward a buy stance across medium and long horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near technical support with upside potential
- Oversold RSI suggesting a rebound
- Recent earnings beat reinforcing momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value indicates ~11% upside
- Sustainable 3% dividend yield
- Strong loan growth and solid profitability metrics
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent dividend payments with low payout ratio
- Stable balance sheet and low leverage
- Undervalued relative to peers and industry averages
Key Metrics & Analysis
Financial Health
Revenue Growth7.80%
Profit Margin29.96%
P/E Ratio13.1
ROE15.47%
ROA1.28%
P/B Ratio1.9
Op. Cash Flow$807.4M
Industry P/E16.6
Technical Analysis
TrendBullish
RSI37.3
Support$133.36
Resistance$147.33
MA 20$140.29
MA 50$138.19
MA 200$132.10
MACDBearish
VolumeStable
Fear & Greed Index88.04
Valuation
Fair Value$206.24
Target Price$149.93
Upside/Downside11.38%
GradeUndervalued
TypeBlend
Dividend Yield3.05%
Risk Assessment
Beta0.75
Volatility20.21%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.